Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomePreferred Shares IssuedShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

vTv Therapeutics (VTVT) Long-Term Debt Repayments: 2013-2024

Historic Long-Term Debt Repayments for vTv Therapeutics (VTVT) over the last 11 years, with Dec 2024 value amounting to $191,000.

  • vTv Therapeutics' Long-Term Debt Repayments was N/A to $64,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $630,000, marking a year-over-year change of. This contributed to the annual value of $191,000 for FY2024, which is 68.11% down from last year.
  • As of FY2024, vTv Therapeutics' Long-Term Debt Repayments stood at $191,000, which was down 68.11% from $599,000 recorded in FY2023.
  • vTv Therapeutics' Long-Term Debt Repayments' 5-year high stood at $5.5 million during FY2020, with a 5-year trough of $191,000 in FY2024.
  • Its 3-year average for Long-Term Debt Repayments is $532,667, with a median of $599,000 in 2023.
  • As far as peak fluctuations go, vTv Therapeutics' Long-Term Debt Repayments tumbled by 86.90% in 2021, and later rose by 13.01% in 2022.
  • vTv Therapeutics' Long-Term Debt Repayments (Yearly) stood at $5.5 million in 2020, then plummeted by 86.90% to $715,000 in 2021, then increased by 13.01% to $808,000 in 2022, then dropped by 25.87% to $599,000 in 2023, then slumped by 68.11% to $191,000 in 2024.